Atlas Trials

Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy

Clinical trial NCT07214103 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07214103
Sponsor
University Hospital, Strasbourg, France
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Septic ShockCoagulopathy
Start date
2027-08-01
Primary completion
2032-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.